{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:06:31Z","timestamp":1790240791522,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.coviro.2016.12.002","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T18:16:39Z","timestamp":1484158599000},"page":"89-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Antibody-dependent cellular cytotoxicity and influenza virus"],"prefix":"10.1016","volume":"22","author":[{"given":"Hillary A","family":"Vanderven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinthujan","family":"Jegaskanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam K","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2016.12.002_bib0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.12.002_bib0010","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.4049\/jimmunol.130.5.2142","article-title":"Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody\u2013antigen interaction on the lymphocyte membrane","volume":"130","author":"Perussia","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0065-2776(08)60845-7","article-title":"Characterization of functional surface structures on human natural killer cells","volume":"42","author":"Ritz","year":"1988","journal-title":"Adv Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0020","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.12.002_bib0025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0030","series-title":"NK Cell Mediated Cytotoxicity: Receptors, Signaling and Mechanisms","author":"Lotzova","year":"1992"},{"key":"10.1016\/j.coviro.2016.12.002_bib0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fimmu.2013.00076","article-title":"Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies","volume":"4","author":"Seidel","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0040","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.4049\/jimmunol.142.4.1102","article-title":"Activation of cloned human natural killer cells via Fc gamma RIII","volume":"142","author":"Werfel","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0045","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1073\/pnas.1012356108","article-title":"Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation","volume":"108","author":"De Maria","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.12.002_bib0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1172\/JCI2323","article-title":"Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro","volume":"102","author":"Oliva","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2016.12.002_bib0055","doi-asserted-by":"crossref","first-page":"e1005315","DOI":"10.1371\/journal.ppat.1005315","article-title":"Polyfunctional HIV-specific antibody responses are associated with spontaneous HIV control","volume":"12","author":"Ackerman","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2016.12.002_bib0060","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1128\/JVI.01023-12","article-title":"Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family","volume":"86","author":"Bonsignori","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0065","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.12.002_bib0070","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/QAD.0b013e328329f97d","article-title":"Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers","volume":"23","author":"Lambotte","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2016.12.002_bib0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/imm.12016","article-title":"Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection","volume":"138","author":"Wren","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.coviro.2016.12.002_bib0080","doi-asserted-by":"crossref","first-page":"11828","DOI":"10.1128\/JVI.00643-07","article-title":"Induction of epitope-specific neutralizing antibodies against West Nile virus","volume":"81","author":"Oliphant","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0085","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1128\/JVI.00551-06","article-title":"Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus","volume":"80","author":"Throsby","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0090","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.1128\/JVI.05859-11","article-title":"Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms","volume":"85","author":"Vogt","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0095","unstructured":"World Health Organization. Influenza (Seasonal). Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs211\/en\/. [Accessed 05 February 2015]."},{"key":"10.1016\/j.coviro.2016.12.002_bib0100","unstructured":"Center for Disease Control and Prevention. Estimated Influenza Illnesses and Hospitalizations Averted by Vaccination\u2014United States, 2014\u201315 Influenza Season. Available at: http:\/\/www.cdc.gov\/flu\/about\/disease\/2014-15.htm. [Accessed 18 August 2016]."},{"key":"10.1016\/j.coviro.2016.12.002_bib0105","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3201\/eid1707.101959","article-title":"Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010","volume":"17","author":"Fielding","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2016.12.002_bib0110","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1099\/vir.0.058636-0","article-title":"Evaluation of heterosubtypic cross-protection against highly pathogenic H5N1 by active infection with human seasonal influenza A virus or trivalent inactivated vaccine immunization in ferret models","volume":"95","author":"Park","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0115","first-page":"153","article-title":"Influenza A: understanding the viral life cycle","volume":"82","author":"Samji","year":"2009","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.coviro.2016.12.002_sbref0120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2016.12.002_sbref0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2016.12.002_bib0130","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/infdis\/jiu334","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses","volume":"210","author":"Jegaskanda","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.12.002_bib0135","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1128\/JVI.00285-16","article-title":"Antibody responses with Fc-mediated functions after vaccination of HIV-infected subjects with trivalent influenza vaccine","volume":"90","author":"Kristensen","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ebiom.2016.04.029","article-title":"What lies beneath: antibody-dependent natural killer cell activation by antibodies to internal influenza virus proteins","volume":"8","author":"Vanderven","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coviro.2016.12.002_bib0145","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4049\/jimmunol.1502551","article-title":"Dimeric FcgammaR ectodomains as probes of the Fc receptor function of anti-influenza virus IgG","volume":"197","author":"Wines","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0150","doi-asserted-by":"crossref","first-page":"13706","DOI":"10.1128\/JVI.01666-13","article-title":"Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques","volume":"87","author":"Jegaskanda","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0155","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies","volume":"190","author":"Jegaskanda","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0160","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/infdis\/jit294","article-title":"Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1","volume":"208","author":"Jegaskanda","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.12.002_sbref0165","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/infdis\/jiw262","article-title":"Generation and protective ability of influenza virus-specific antibody-dependent cellular cytotoxicity in humans elicited by vaccination, natural infection, and experimental challenge","volume":"214","author":"Jegaskanda","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.12.002_bib0170","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1128\/JVI.03030-12","article-title":"Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques","volume":"87","author":"Jegaskanda","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.12.002_sbref0175","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1073\/pnas.1609316113","article-title":"Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus","volume":"113","author":"He","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.12.002_bib0180","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.4049\/jimmunol.119.6.2100","article-title":"Lymphocyte cytotoxicity to influenza virus-infected cells. II. Requirement for antibody and non-T lymphocytes","volume":"119","author":"Greenberg","year":"1977","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0185","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/iai.20.3.640-645.1978","article-title":"Lymphocyte cytotoxicity to influenza virus-infected cells: response to vaccination and virus infection","volume":"20","author":"Greenberg","year":"1978","journal-title":"Infect Immun"},{"key":"10.1016\/j.coviro.2016.12.002_bib0190","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1073\/pnas.76.9.4622","article-title":"Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation","volume":"76","author":"Greenberg","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.12.002_bib0195","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/infdis\/148.5.785","article-title":"Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells","volume":"148","author":"Hashimoto","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.12.002_sbref0200","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/infdis\/jiv181","article-title":"High antibody-dependent cellular cytotoxicity antibody titers to H5N1 and H7N9 avian influenza A viruses in healthy US adults and older children","volume":"212","author":"Terajima","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.12.002_bib0205","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.126.5.1814","article-title":"Expression of influenza A virus internal antigens on the surface of infected P815 cells","volume":"126","author":"Yewdell","year":"1981","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0210","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.12.002_bib0215","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJMoa0904023","article-title":"Severe respiratory disease concurrent with the circulation of H1N1 influenza","volume":"361","author":"Chowell","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.12.002_bib0220","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1056\/NEJMc0907256","article-title":"Older age and a reduced likelihood of 2009 H1N1 virus infection","volume":"361","author":"Fisman","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.12.002_bib0225","first-page":"15","article-title":"Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October\u2013December 2009","author":"McVernon","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.coviro.2016.12.002_bib0230","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(09)62126-7","article-title":"Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study","volume":"375","author":"Miller","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2016.12.002_bib0235","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/vim.2016.0003","article-title":"Vaccination with 2014-15 seasonal inactivated influenza vaccine elicits cross-reactive anti-HA antibodies with strong ADCC against antigenically drifted circulating H3N2 virus in humans","volume":"29","author":"Zhong","year":"2016","journal-title":"Viral Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0240","series-title":"Preceedings of the 9th Options for the Control of Influenza","article-title":"Antibody dependent cellular cytotoxicity immune response to seasonal influenza vaccination in the elderly","author":"Vanderven","year":"2016"},{"key":"10.1016\/j.coviro.2016.12.002_bib0245","doi-asserted-by":"crossref","first-page":"ofw102","DOI":"10.1093\/ofid\/ofw102","article-title":"Antibody-dependent cell-mediated cytotoxicity to hemagglutinin of influenza A viruses after influenza vaccination in humans","volume":"3","author":"Zhong","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.coviro.2016.12.002_bib0250","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/CVI.00339-13","article-title":"In vitro assessment of the immunological significance of a human monoclonal antibody directed to the influenza a virus nucleoprotein","volume":"20","author":"Bodewes","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0255","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0260","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.4049\/jimmunol.1003057","article-title":"Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus","volume":"186","author":"LaMere","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0265","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2016.12.002_bib0270","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2008.06.002","article-title":"Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein","volume":"80","author":"Wang","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.12.002_bib0275","doi-asserted-by":"crossref","first-page":"e0124677","DOI":"10.1371\/journal.pone.0124677","article-title":"A human anti-M2 antibody mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and cytokine secretion by resting and cytokine-preactivated natural killer (NK) cells","volume":"10","author":"Simhadri","year":"2015","journal-title":"PLoS One"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716302073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716302073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T05:56:30Z","timestamp":1749880590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625716302073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":55,"alternative-id":["S1879625716302073"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2016.12.002","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-dependent cellular cytotoxicity and influenza virus","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2016.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}